?The effect of Atorvastatin therapy in COVID-19

Phase 2

Recruiting

• Conditions: COVID-19.; COVID-19, virus identified; U07.1

• Registration Number: IRCT20190831044653N5
• Lead Sponsor: Bojnourd University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 September 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

COVID-19 infected people who are inpatient in the hospital

Exclusion Criteria

type 1 diabetes
ketoacidosis
Uncompensated heart failure
sever renal failure GFR<30ml/min
metabolic acidosis
structural respiratory dysfunction
Indications for Intubation at the registering time to the hospital

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hospitalization. Timepoint: end of study. Method of measurement: Patient file in the hospital.

Secondary Outcome Measures

Name	Time	Method
Mortality rate. Timepoint: end of study. Method of measurement: Patient file in the hospital.;Intubation indication. Timepoint: end of study. Method of measurement: Patient file in the hospital.;Duration of intubation. Timepoint: end of study. Method of measurement: Patient file in the hospital.;Duration of sign and symptoms (fever, cough ,...). Timepoint: daily. Method of measurement: Patient file in the hospital and questionnaire.